# US 2020/0395100 A1 · Population based treatment recommender using cell free dna

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0395100 A1
- Document ID: US20200395100A1
- Status: Published application
- Kind: A1
- Application number: 17/003,631
- Filed: 2020-08-26
- Published: 2020-12-17
- Earliest claimed: 2015-10-09
- Assignees: Guardant Health, Inc.
- Applicants: Guardant Health, Inc.
- Inventors: Helmy ELTOUKHY; AmirAli TALASAZ
- Web page: https://patentgrep.com/patent/US20200395100A1

## CPC

- G16B 50/20: Heterogeneous data integration
- C12Q 1/6883: for diseases caused by alterations of genetic material
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B 40/20: Supervised data analysis
- G16B 40/30: Unsupervised data analysis
- G16B 50/00: ICT programming tools or database systems specially adapted for bioinformatics
- G16H 20/00: ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H 50/30: for calculating health indices; for individual health risk assessment
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Systems and methods are disclosed for generating a therapeutic response predict or detecting a disease, by: using a genetic analyzer to generate genetic information; receiving into computer memory a training dataset comprising, for each of a plurality of individuals having a disease, (1) genetic information from the individual generated at first time point and (2) treatment response of the individual to one or more therapeutic interventions determined at a second, later, time point; and implementing a machine learning algorithm using the dataset to generate at least one computer implemented classification algorithm, wherein the classification algorithm, based on genetic information from a subject, predicts therapeutic response of the subject to a therapeutic intervention.

## Claims

### Claim 1

A method of generating a system, the method comprising:
storing genetic and clinical information obtained from each of a plurality of subjects in at least one database, wherein the genetic information from a given subject in the plurality of subjects is determined from cell-free nucleic acids (cfNAs) obtained from the given subject at two or more time points;
operably connecting at least one extractor to the at least one database, which extractor is configured to extract one or more features from the genetic and clinical information stored in the at least one database; and,
operably connecting at least one recommender to the at least one extractor, thereby generating the system.

### Claim 2 (depends on 1)

The method of claim 1, wherein the plurality of subjects comprises subjects having cancer.

### Claim 3 (depends on 1)

The method of claim 1, wherein the plurality of subjects comprises healthy subjects.

### Claim 4 (depends on 1)

The method of claim 1, further comprising operably connecting at least one genetic analyzer to the system, which genetic analyzer is configured to the genetic information.

### Claim 5 (depends on 1)

The method of claim 1, further comprising operably connecting at least one report generator to the recommender,

### Claim 6 (depends on 1)

The method of claim 1, wherein the genetic information comprises unstructured text data.

### Claim 7 (depends on 1)

The method of claim 1, comprising storing the clinical information in at least one database array.

### Claim 8 (depends on 1)

The method of claim 1, wherein the clinical information comprises patient information from physicians and test labs.

### Claim 9 (depends on 1)

The method of claim 1, wherein the clinical information comprises CT scans, MM scans, ultrasound scans, bone scans, PET scans, bone marrow tests, X-rays, endoscopies, lymphangiograms, intravenous urograms (IVU), IV pyelograms (IVP), lumbar punctures, cystoscopies, immunological tests, histology reports, and/or cancer marker tests.

### Claim 10 (depends on 1)

The method of claim 1, further comprising using the system to predict a course of treatment for at least one test subject having cancer.

### Claim 11 (depends on 1)

The system generated by the method of claim 1.

### Claim 12 (depends on 1)

The method of claim 1, further comprising operably connecting at least one classifier to the extractor and to the recommender, which classifier is configured to classify the one or more features extracted from the genetic and clinical information.

### Claim 13 (depends on 13)

The method of claim 13, comprising training the classifier by:
(a) providing a plurality of different classes, wherein each class represents a set of subjects with a shared characteristic;
(b) providing a multi-parametric model representative of the cfNAs from each of a plurality of samples belonging to each of the classes, thereby providing a training data set; and
(c) training a learning algorithm on the training data set to create one or more trained classifiers, wherein each trained classifier classifies a test sample into one or more of the plurality of classes.

### Claim 14 (depends on 13)

The method of claim 13, wherein the plurality of different classes is selected from the group consisting of: healthy, breast cancer, colon cancer, lung cancer, pancreatic cancer, prostate cancer, ovarian cancer, melanoma, and liver cancer.

### Claim 15 (depends on 12)

The method of claim 12, wherein the one or more features comprise treatment responses to therapeutic interventions to generate one or more treatment classifications.

### Claim 16 (depends on 15)

The method of claim 15, wherein the one or more treatment classifications comprise responsive to treatment, nonresponsive to treatment, or a level of responsiveness to treatment.

### Claim 17 (depends on 12)

The method of claim 12, wherein the classifier comprises one or more artificial neural networks, random forests, linear classifiers, support vector machines, and/or Hidden Markov models (HMMs).

### Claim 18 (depends on 17)

The method of claim 17, comprising training the artificial neural networks using a Bayesian framework.

### Claim 19 (depends on 12)

The method of claim 12, further comprising operably connecting at least one inference unit to the classifier and to the recommender.

### Claim 20 (depends on 19)

The method of claim 19, wherein output of the classifier is provided to the inference unit.
